Published in J Clin Endocrinol Metab on December 01, 1999
Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. Proc Natl Acad Sci U S A (2003) 1.06
A new "new" syndrome in the new world: is multiple postreceptor steroid hormone resistance due to a coregulator defect? J Clin Endocrinol Metab (1999) 0.86
Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study. Reprod Biol Endocrinol (2010) 0.84
Studies of a co-chaperone of the androgen receptor, FKBP52, as candidate for hypospadias. Reprod Biol Endocrinol (2007) 0.84
ZNF764 haploinsufficiency may explain partial glucocorticoid, androgen, and thyroid hormone resistance associated with 16p11.2 microdeletion. J Clin Endocrinol Metab (2012) 0.80
Genome-wide Regulatory Roles of the C2H2-type Zinc Finger Protein ZNF764 on the Glucocorticoid Receptor. Sci Rep (2017) 0.75
An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med (1981) 7.35
Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". J Exp Med (1994) 4.41
Activation of PPARgamma coactivator-1 through transcription factor docking. Science (1999) 4.33
Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med (1991) 2.93
Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat Med (1996) 2.71
The ROOT MERISTEMLESS1/CADMIUM SENSITIVE2 gene defines a glutathione-dependent pathway involved in initiation and maintenance of cell division during postembryonic root development. Plant Cell (2000) 2.51
Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41
A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunol Methods (1998) 2.22
Generalized lymphadenopathy in homosexual men. Ann Intern Med (1983) 2.09
Isolation, characterization, and mapping of Escherichia coli mutants blocked in the synthesis of ornithine decarboxylase. J Bacteriol (1975) 2.07
Anaesthesia for caesarean section in a patient with Charcot-Marie-Tooth disease. Anaesthesia (1998) 2.03
Training in obstetric general anaesthesia: a vanishing art? Anaesthesia (2000) 1.94
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med (2000) 1.94
Localization of the binding site for protein S4 on 16 S ribosomal RNA by chemical and enzymatic probing and primer extension. J Mol Biol (1986) 1.83
Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression. AIDS Res Hum Retroviruses (1999) 1.80
Cortisol production rate in childhood and adolescence. J Pediatr (1990) 1.66
The incidental adrenal mass. Am J Med (1996) 1.65
Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor. J Alzheimers Dis (2000) 1.61
A community ability scale for chronically mentally ill consumers: Part I. Reliability and validity. Community Ment Health J (1994) 1.59
Acquired immunodeficiency syndrome in male prisoners. New insights into an emerging syndrome. Ann Intern Med (1983) 1.58
Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol (1987) 1.53
Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations. J Clin Endocrinol Metab (1999) 1.52
Variations in hospitalization rates for asthma among black and minority ethnic communities. Respir Med (1998) 1.51
Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med (1987) 1.50
Regional blockade for delivery in women with scoliosis or previous spinal surgery. Int J Obstet Anesth (2003) 1.50
Autonomous splicing and complementation of in vivo-assembled spliceosomes. J Cell Biol (1989) 1.49
Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol (1994) 1.47
The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.46
Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord (2003) 1.45
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med (1986) 1.45
Re.: Purification of IgG monoclonal antibody by caprylic acid precipitation. J Immunol Methods (1983) 1.45
MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer (2009) 1.44
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab (1991) 1.40
True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab (1984) 1.40
Cimetidine is an antiandrogen in the rat. Gastroenterology (1979) 1.40
Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1. J Immunol (1985) 1.39
Myeloperoxidase mRNA analysis in acute lymphoblastic leukemia. Diagn Mol Pathol (1996) 1.38
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol (1998) 1.36
The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med (1984) 1.36
Postthymic development of CD28-CD8+ T cell subset: age-associated expansion and shift from memory to naive phenotype. J Immunol (1999) 1.34
Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg (1996) 1.31
Hypothalamic dysfunction in patients with anorexia nervosa. Medicine (Baltimore) (1974) 1.31
Discourse comprehension and problem solving: decisions about the treatment of breast cancer by women across the life span. Psychol Aging (1995) 1.30
Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann Intern Med (1984) 1.27
Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med (1983) 1.26
Time to peak serum antibody response to influenza vaccine. Clin Diagn Lab Immunol (1995) 1.25
A community ability scale for chronically mentally ill consumers: Part II. Applications. Community Ment Health J (1994) 1.24
Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab (2001) 1.23
Time to peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol (1996) 1.22
Central electrophysiologic correlates of pulsatile luteinizing hormone secretion in the rhesus monkey. Neuroendocrinology (1984) 1.22
Detection of a sub-set of polysomal mRNAs associated with modulation of hypusine formation at the G1-S boundary. Proposal of a role for eIF-5A in onset of DNA replication. FEBS Lett (1995) 1.21
Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc Natl Acad Sci U S A (1989) 1.20
Kaposi's sarcoma. Gastrointestinal involvement correlation with skin findings and immunologic function. Dig Dis Sci (1984) 1.20
Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. J Clin Endocrinol Metab (1987) 1.19
Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest (1982) 1.18
Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab (1988) 1.18
The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. J Pediatr (1986) 1.18
Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome. Cancer Res (1986) 1.17
Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab (1981) 1.17
Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. N Engl J Med (1981) 1.16
The beta-amyloid precursor protein APP is tyrosine-phosphorylated in cells expressing a constitutively active form of the Abl protoncogene. J Biol Chem (2001) 1.16
A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol (1999) 1.16
Stimulation of human T lymphocytes by PHA-activated autologous T lymphocytes: analysis of the role of Ia-like antigens with monoclonal antibodies. Immunogenetics (1981) 1.16
Mechanisms of corticosteroid action on lymphocyte subpopulations. VI. Lack of correlation between glucocorticosteroid receptors and the differential effects of glucocorticosteroids on T-cell subpopulations. Cell Immunol (1980) 1.16
A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. N Engl J Med (1983) 1.16
Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene (2010) 1.15
Variations in admissions to hospital for head injury and assault to the head. Part 1: Age and gender. Br J Oral Maxillofac Surg (1999) 1.15
The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics (1983) 1.15
Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood (1997) 1.14
Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab (1985) 1.14
Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med (1986) 1.13
The measurement of estrone sulfate in plasma. Steroids (1971) 1.13
Adrenarche: a survey of rodents, domestic animals, and primates. Endocrinology (1978) 1.13
Equivalent dose of ephedrine and phenylephrine in the prevention of post-spinal hypotension in Caesarean section. Br J Anaesth (2005) 1.12
Altered immune function in a morbidly obese pediatric population. Ann N Y Acad Sci (1993) 1.10
Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist. J Steroid Biochem (1988) 1.09
Tricuspid regurgitation secondary to mitral valve disease: tricuspid annulus function as guide to tricuspid valve repair. Cardiovasc Surg (2001) 1.09
Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg (1994) 1.08
Variations in admission to hospital for head injury and assault to the head. Part 2: Ethnic group. Br J Oral Maxillofac Surg (1999) 1.08
Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab (1998) 1.08
Effects of nutritional status on immunological function. Am J Clin Nutr (1982) 1.07
Serum suppression of lymphocyte activation in vitro in acquired immunodeficiency disease. J Clin Immunol (1983) 1.07
Diabetes mellitus and optic atrophy with associated findings of diabetes insipidus and neurosensory hearing loss in two siblings. Arch Intern Med (1974) 1.06
Hormones, emotional dispositions, and aggressive attributes in young adolescents. Child Dev (1987) 1.06
Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. Proc Natl Acad Sci U S A (1982) 1.06
Oxytocin receptor gene expression in the rat uterus during pregnancy and the estrous cycle and in response to gonadal steroid treatment. Endocrinology (1995) 1.06
Usefulness of inferior petrosal sinus venous endocrine markers in Cushing's disease. J Neurosurg (1988) 1.06
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci U S A (1999) 1.05
Cerebellar involvement in multifocal eosinophilic granuloma: demonstration by computerized tomographic scanning. Ann Neurol (1980) 1.05
Sensitive test for thyroid hormone autoantibodies in serum. Lancet (1982) 1.05
The polyendocrine deficiency syndromes. N Engl J Med (1985) 1.04
A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab (1993) 1.04
Defective cellular immune response in vitro in common variable immunodeficiency. J Clin Immunol (1981) 1.03
Response to wheat antigen in in vitro lymphocyte transformation among HLA-B8-positive normal donors. Transplant Proc (1978) 1.03
Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation (1982) 1.03
Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology (1989) 1.02